Product Information

TOPIRAMATE ER 200 MG SPRINK CAP is a generic product labeled by NorthStar Rx LLC, priced at $9.6713 per EA under NDC 72603012401. Its NADAC has been published 173 times since May 3, 2023.

FDA first approved this application on Feb 1, 2021. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TOPIRAMATE ER 200 MG SPRINK CAP

topiramate
$9.6713per EA

Strength

200 mg/1

Manufacturer

NorthStar Rx LLC

NDC

72603012401

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210278

FDA Approved

2/1/2021

TE Code

AB2

On Market Since

1/1/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 200 MG SPRINK CAP has been published 173 times since May 3, 2023, and over the history we have for it it has declined 46.5%. The table below summarizes its recorded NADAC range and movement.

Current price$9.6713 per EA
All-time high$18.0838 (Dec 13, 2023)
All-time low$9.6713 (Aug 19, 2026)
52-week high$13.4402
52-week low$9.6713
Median price$13.4889
Average price$14.0742
Largest weekly change+34.1% (Jan 17, 2024)
Weeks tracked173
Tracking sinceMay 3, 2023

Price History

1W

-8.1%

1M

-8.1%

3M

-15.7%

6M

-14.0%

1Y

-28.0%

3Y

-46.5%

5Y

N/A

All

-46.5%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 200 MG SPRINK CAP?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 200 MG SPRINK CAP, manufactured by NorthStar Rx LLC, is $9.6713 per EA (NDC 72603012401), effective Aug 19, 2026.

How has the price of TOPIRAMATE ER 200 MG SPRINK CAP changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 200 MG SPRINK CAP has declined 46.5%. It has been tracked across 173 weekly CMS publications since May 3, 2023.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 200 MG SPRINK CAP?

Since May 3, 2023, the NADAC for TOPIRAMATE ER 200 MG SPRINK CAP has ranged from a low of $9.6713 (Aug 19, 2026) to a high of $18.0838 (Dec 13, 2023), with a median of $13.4889 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 200 MG SPRINK CAP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TOPIRAMATE ER 200 MG SPRINK CAP in a comparable dosage form, but none are currently priced below it.

Who manufactures TOPIRAMATE ER 200 MG SPRINK CAP?

TOPIRAMATE ER 200 MG SPRINK CAP (NDC 72603012401) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.